CYCLERION THERAPEUTICS, INC. (KRSA) Net income 2018–2025
CYCLERION THERAPEUTICS, INC. (KRSA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$3.5MFY2025 · since FY2018: -$115.3M → -$3.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.5M | -15.4% |
| FY2024 | -$3.1M | +41.9% |
| FY2023 | -$5.3M | +88.1% |
| FY2022 | -$44.1M | +14.7% |
| FY2021 | -$51.6M | +33.6% |
| FY2020 | -$77.8M | +36.8% |
| FY2019 | -$123.0M | -6.7% |
| FY2018 | -$115.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRSA financial trends
KRSA RevenueKRSA Net marginKRSA Gross profitKRSA Gross marginKRSA Operating incomeKRSA Operating marginKRSA Operating cash flowKRSA Free cash flowKRSA Capital expendituresKRSA Return on equityKRSA Stock buybacksKRSA Dividends paidKRSA Total assetsKRSA Total liabilitiesKRSA Shareholders’ equityKRSA overview →